Cancer stem cell vaccination confers significant antitumor immunity
about
Anti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical AppraisalTargeting head and neck tumoral stem cells: From biological aspects to therapeutic perspectivesImmune responses to human cancer stem-like cells/cancer-initiating cellsDendritic cell-based vaccination in cancer: therapeutic implications emerging from murine modelsImmunotargeting of cancer stem cellsTargeting Head and Neck Cancer Stem Cells: Current Advances and Future ChallengesD-K6L 9 peptide combination with IL-12 inhibits the recurrence of tumors in mice.CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells.Heat shock protein DNAJB8 is a novel target for immunotherapy of colon cancer-initiating cells.A new strategy using ALDHhigh-CD8+T cells to inhibit tumorigenesis.Cancer stem cell vaccine inhibits metastases of primary tumors and induces humoral immune responses against cancer stem cellsConcise Review: Targeting Cancer Stem Cells Using Immunologic ApproachesDendritic Versus Tumor Cell Presentation of Autologous Tumor Antigens for Active Specific Immunotherapy in Metastatic Melanoma: Impact on Long-Term Survival by Extent of Disease at the Time of Treatment.Immunobiology and signaling pathways of cancer stem cells: implication for cancer therapy.Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche.Effect of targeted ovarian cancer immunotherapy using ovarian cancer stem cell vaccine.Head and Neck Cancer Stem Cells: From Identification to Tumor Immune NetworkCancer stem cell vaccine expressing ESAT-6-gpi and IL-21 inhibits melanoma growth and metastasesProstate cancer stem cells are targets of both innate and adaptive immunity and elicit tumor-specific immune responsesImmunotherapy with dendritic cells and cytokine-induced killer cells for MDA-MB-231 breast cancer stem cells in nude mice.Therapeutic Efficacy of Cancer Stem Cell Vaccines in the Adjuvant SettingPromise of cancer stem cell vaccine.Characterization of a novel transgenic mouse tumor model for targeting HER2+ cancer stem cells.New development in CAR-T cell therapy.Designer vaccine nanodiscs for personalized cancer immunotherapy.Repositioning therapeutic cancer vaccines in the dawning era of potent immune interventions.Preclinical vaccines against mammary carcinoma.Various ways to improve whole cancer cell vaccines.Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective.Breast cancer stem cells and the immune system: promotion, evasion and therapy.Cancer stem cells converted from pluripotent stem cells and the cancerous niche.The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies.Therapeutic vaccination based on side population cells transduced by the granulocyte-macrophage colony-stimulating factor gene elicits potent antitumor immunity.Novel method of cell line establishment utilizing fluorescence-activated cell sorting resulting in 6 new head and neck squamous cell carcinoma lines.Cancer Stem Cells in Squamous Cell Carcinoma.Preventive cancer stem cell-based vaccination reduces liver metastasis development in a rat colon carcinoma syngeneic model.Prospective study of the safety and efficacy of a pancreatic cancer stem cell vaccine.Safety and efficacy study of lung cancer stem cell vaccine.Generation of a novel dendritic-cell vaccine using melanoma and squamous cancer stem cells.Necrosis and apoptosis in Trichinella spiralis-mediated tumour reduction
P2860
Q26744536-9623F597-1263-4BD2-9062-1BC7DCE81273Q26770039-47FBAEA1-6E27-47A8-9F53-439C44E257FFQ26781794-8EF9365E-06F9-48F1-A611-B26BC6918407Q27012618-C71BD8D8-43BB-4D9C-88B9-E3E1DCD4A598Q27014031-050A6927-C954-43ED-9292-86440B0C699CQ33793000-557521F2-C47B-4EFD-8183-7E0227361527Q33883123-F6CF01CA-6BB1-4E83-98BB-F028AD0478C2Q34476278-CE7B6EC1-C26B-4F81-ADC6-286A9F8FA3AFQ35051440-4610DC72-C3BB-4AAE-AE77-2B88A67D1723Q35221936-70F565DA-6700-42B2-97EA-7786F8B25CD3Q35507539-4C288876-F858-468F-9FB3-17F677F675C4Q35772708-8E546027-F3FB-4449-8B1B-73041E06679BQ35821826-0182BCB7-A861-48A3-AD31-09143E99897CQ35984406-638002BD-BDDE-4D27-A316-8285E06190E3Q36165598-E27C8208-04DE-495B-8CE5-35DC16825651Q36204651-B2F3817B-BB55-4BF2-806F-ED197EA03994Q36212296-8A723756-392A-407C-B293-A921DE2B5D9BQ36309496-5F98F8B0-3286-4E2D-8EEC-F8E6B280B70BQ36887869-405B6712-734C-4848-AE05-E418360E1EF3Q37144025-7F221336-E85F-42B5-93BB-D06D47990CDDQ37180487-76C3D3E7-68A5-4E98-8C2D-D873D7D70207Q37320126-C608C4A8-C817-4111-AF7F-7DBB3558F481Q37428738-39E2A66E-B03D-477C-9606-DD0BB86D1F84Q37658246-B850F2E6-D4FA-4212-9030-9BD428C34600Q37730767-2D6A9689-5587-41CA-8ED2-126AE0EC6BF7Q38149916-43C27224-805F-401A-9A43-4C1DF33DA401Q38160252-75BC8568-BBBA-47FC-853E-1705B0BB02E6Q38206582-EE17634C-C1E6-48C1-A4C5-8FF0227F0CAFQ38212354-FB2392B0-2911-4827-8A7F-DD68BC763772Q38226597-8AED4AC9-89D8-45FE-B648-1F052FA1A5CFQ38235250-D218D5E9-8B67-4F3E-895D-C4ACCC79B41CQ38645695-0992C6F8-4406-4956-AA02-9DEA93A21D36Q38721508-D4D65431-3285-482E-B1E1-BBF82C2E4F10Q38910205-C31411AF-290F-45B1-A722-54FB593DA35DQ38957139-F5D59A78-187B-464B-B043-CD036A677677Q39236143-F5C4F01D-CAE8-46CB-8323-4CC6F4DC9487Q40161224-38811D3B-56EF-41E3-A8E7-EE7EC1E254C5Q40166620-95FA9A73-B765-4B26-9B00-62F9D333084DQ40890666-B2E1C385-5455-4404-AC36-16321379D5A2Q41118116-1109AEF2-5895-4995-B1A9-1537D62E36B6
P2860
Cancer stem cell vaccination confers significant antitumor immunity
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Cancer stem cell vaccination confers significant antitumor immunity
@ast
Cancer stem cell vaccination confers significant antitumor immunity
@en
type
label
Cancer stem cell vaccination confers significant antitumor immunity
@ast
Cancer stem cell vaccination confers significant antitumor immunity
@en
prefLabel
Cancer stem cell vaccination confers significant antitumor immunity
@ast
Cancer stem cell vaccination confers significant antitumor immunity
@en
P2093
P2860
P1433
P1476
Cancer stem cell vaccination confers significant antitumor immunity
@en
P2093
Alfred E Chang
Fang Zheng
Jeffrey S Moyer
Mark E P Prince
Martin Egenti
Max S Wicha
P2860
P304
P356
10.1158/0008-5472.CAN-11-1400
P407
P577
2012-04-01T00:00:00Z